The authors pooled individual patient data from nine trials comparing exercise training with standard care. They concluded that exercise training is associated with a significant reduction in mortality. The lack of individual trial results and the statistical methods used make it difficult to assess the reliability of the conclusions.
Authors' objectives
To determine the effect of exercise training on survival in patients with heart failure caused by left ventricular dysfunction.
Searching
The authors searched MEDLINE, reference lists of review articles, and abstracts presented at scientific meetings and published in Circulation, the Journal of the American College of Cardiology and the European Heart Journal. They also consulted researchers in exercise physiology and heart failure. A subsequent search of the Cochrane Database of Systematic Reviews did not identify any further studies.
A collaborative group was established to conduct the meta-analysis. A prospective protocol was written and agreed before any data collection or analysis took place.
Study selection

Study designs of evaluations included in the review
The review included individual patient data (IPD) from randomised controlled trials (RCTs).
Specific interventions included in the review
Studies of exercise programmes (without other simultaneous interventions) lasting 8 weeks or more and involving training of at least both legs were eligible for inclusion; survival follow-up of at least 3 months was also required. The duration of training in the included studies ranged from 8 weeks to over a year, and the intensity ranged from 50 to 80% of peak oxygen consumption or peak heart rate.
Participants included in the review
The participants were required to be patients with chronic heart failure (stable for at least 3 months) associated with left ventricular dysfunction (a left ventricular ejection fraction, LVEF, of less than 50%). The participants in the included studies were mostly male (88%) with a mean age of 60 years, mean LVEF of 27% and mean New York Heart Association (NYHA) functional class of 2.5. The majority were taking angiotensin-converting enzyme inhibitors (73%) and diuretics (69%).
Outcomes assessed in the review
The primary outcome was time to death from any cause. A secondary outcome was a composite of death and time to first admission to hospital (for any reason).
How were decisions on the relevance of primary studies made?
